United Therapeutics (UTHR) EBITDA (2009 - 2026)
United Therapeutics' EBITDA came in at $355 million for Q2 2026, down 7.9% from $385.6 million a year earlier but up 1.9% from the prior quarter.
Powered by 
Analysis
United Therapeutics (UTHR) EBITDA (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, United Therapeutics reported EBITDA of $1.49 billion, down 2.3% year-over-year; for FY2025, it came in at $1.58 billion, up 8.9% from FY2024.
- EBITDA has increased in each of the last four years, with a five-year compound annual growth rate of 19.7% (FY2020 to FY2025).
- Going back by year, EBITDA was $1.45 billion in FY2024 (+17.1%), $1.24 billion in FY2023 (+20.1%), $1.03 billion in FY2022 (+70.2%) and $605.8 million in FY2021 (-5.9%).
- The five-year range for quarterly EBITDA is $182.4 million (Q4 2021) to $410.4 million (Q3 2025).
- Year-over-year, EBITDA increased in six of the last eight quarters, with growth averaging 7.4%.
- The fastest year-over-year change in EBITDA over five years came in Q4 2021 (growth of 132.7%), and the weakest in Q1 2026 (a decline of 13.5%).
- Business Quant data shows UTHR's EBITDA at $348.4 million (Q1 2026), $379.5 million (Q4 2025) and $410.4 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | United Therapeutics | 20.72 Bn | 10.22 Bn | 683.80 Mn | 355.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 355.00 Mn |
| Mar 31, 2026 | 348.40 Mn |
| Dec 31, 2025 | 379.50 Mn |
| Sep 30, 2025 | 410.40 Mn |
| Jun 30, 2025 | 385.60 Mn |
| Mar 31, 2025 | 402.60 Mn |
| Dec 31, 2024 | 377.40 Mn |
| Sep 30, 2024 | 362.20 Mn |
| Jun 30, 2024 | 338.60 Mn |
| Mar 31, 2024 | 371.30 Mn |
| Dec 31, 2023 | 273.80 Mn |
| Sep 30, 2023 | 340.30 Mn |
| Jun 30, 2023 | 326.30 Mn |
| Mar 31, 2023 | 297.70 Mn |
| Dec 31, 2022 | 188.80 Mn |
| Sep 30, 2022 | 327.20 Mn |
| Jun 30, 2022 | 214.50 Mn |
| Mar 31, 2022 | 300.50 Mn |
| Dec 31, 2021 | 182.40 Mn |
| Sep 30, 2021 | 241.10 Mn |
API Access
United Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=UTHR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "UTHR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=UTHR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();